Two distinguished members join Dendrite’s Scientific Advisory Board

Dendrite Clinical Systems has announced the appointment of two members to the company’s newly established Scientific Advisory Board - Sir Bruce Keogh (KBE FMedSci FRCS FRCP) and Professor Anthony Goldstone (CBE MA (Oxon) FRCP FRCPE FRCPath). The Scientific Advisory Board has been created to provide unique advice and guidance to Dendrite’s management team by taking an objective look at our activities and sharing with us their experience and knowledge. This includes evaluating the scientific merit of projects, assessing progress and offering strategic input on the company’s priorities.

13 September 2024

UzAMBS and Dendrite Clinical Systems to establish National Registry of Bariatric and Metabolic Surgery of Uzbekistan

The Association of Bariatric and Metabolic Surgeons of Uzbekistan (UzAMBS) and Dendrite Clinical Systems will establish a National Registry of Bariatric and Metabolic Surgery of Uzbekistan.

6 July 2024

Dendrite and LumiThera initiate EUROLIGHT Registry Study to Evaluate Long-term Benefits of Photobiomodulation (PBM) Treatment using the Valeda® Light Delivery System in Patients with Dry Age-Related Macular Degeneration

Dendrite Clinical Systems and LumiThera have initiated the largest photobiomodulation (PBM) study ever conducted. The multi-center clinical registry, EUROLIGHT (European Union Registry Study) will enroll 500 to 1000 patients treated with with PBM using the LumiThera Valeda Light Delivery System in the EU over the past three years. The study will initially include up to 20 European centres and could be expanded in other countries outside the Europe Union (EU) where Valeda is approved.

4 January 2024

SBMSK and Dendrite Clinical Systems to establish National Registry of Bariatric and Metabolic Surgery of Kazakhstan

The Society of Bariatric and Metabolic Surgeons of Kazakhstan (SBMSK) and Dendrite Clinical Systems will establish a National Registry of Bariatric and Metabolic Surgery of Kazakhstan. The purpose of the Registry is to collect information on patients and bariatric procedures in the country so researchers can use the data to improve outcomes in patients.

25 November 2023

State of Kuwait Ministry of Health publishes 3rd National Bariatric Registry Report

The State of Kuwait Ministry of Health and Dendrite are delighted to announce the publication of the 3rd Kuwait National Bariatric Registry Report 2023. This latest report, which includes 6,484 bariatric surgery cases, contains data on baseline obesity-related disease, operation types, operative outcomes and disease status after bariatric surgery in Kuwait.

23 October 2023

Leading UK clinic to launch Dendrite's comprehensive obesity workflow system

The multi-disciplinary team (MDT) at Luton and Dunstable Hospital's Obesity Clinic, working in conjunction with Dendrite Clinical Systems, have developed a single database that tracks at every stage the patient’s entire treatment pathway. The new system records and collects data from the initial patient referral and pre-clinical assessments to each element of their MDT experience, obesity treatment/s, as well as follow-up appointments.

6 June 2023

History

Dendrite Clinical Systems was established in 1993, by co-directors Dr Peter Walton, Keith Price and Neal McCann, and over the last 26 years the company has become one of the leading suppliers of clinical software to hospitals and institutions in the world. Since its inception, the company has maintained a belief that clinical data collection and analysis is crucial in achieving effective clinical audit and ultimately, improving patient outcomes.

Starting from an office in central London, Dendrite has evolved from a specialist supplier of clinical databases and analysis software, to providing consultancy and publishing services for the international healthcare sector. The company now has two offices in the UK, agents across four continents and has expanded its global user base across hundreds of hospitals, with over 170 national and international registries in more than 40 countries.

Dendrite has continued to develop innovative clinical software solutions, which have been utilised in many different clinical scenarios, fulfilling the company's ethos of providing the tools for effective clinical governance.